Stryker Corporation Stock in the Strategy Check

4.5
Low MatchStockScorer score

Compared with its sector, strongest in Growth and weakest in Momentum.

View all strategies →

Sector profile

50%100%This stock · Profitability: 58%This stock · Growth: 61%This stock · Valuation: 41%This stock · Momentum: 10%This stock · Quality: 40%This stock · Balance sheet & risk: 44%Sector median · Profitability: 50%Sector median · Growth: 50%Sector median · Valuation: 50%Sector median · Momentum: 50%Sector median · Quality: 50%Sector median · Balance sheet & risk: 50%ProfitabilityGrowthValuationMomentumQualityBalance sheet & riskThis stockSector median

Sector rank: 42.2 of 100
Average of the axes, measured against the large and mid caps of the sector in developed markets. 100 means ahead of that peer group in every area.

18Strategies checked

How does Stryker Corporation stock perform across 18 strategies?

Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.

12 more strategies locked

With a free account, you can see the match across all strategies checked in one complete overview.

Stryker Corporation key metrics: P/E, P/B and equity ratio

Selected fundamental metrics for Stryker Corporation.

P/E ratio32.1
P/B ratio4.6
Return on equity (ROE)14.5 %
Equity ratio46.9 %
Debt-to-equity (D/E)0.73
Dividend yield1.3 %
Unlock further metrics

Sign up for free to see further metrics for Stryker Corporation.

Unlock for free →
Peer comparison

Put the company in its peer context

Compare the displayed overall score with the unlocked peer rows on this page.

Bounded preview
Stryker Corporation4.5
Peer median6.4

Based on 3 unlocked peers from this page, not on the entire sector.

Similar stocks in Healthcare

How comparable stocks in the same sector score in the StockScorer model.

SymbolCompanyRating
SYKStryker Corporationthis page
LLYEli Lilly and CompanyMedium6.4
JNJJohnson & JohnsonMedium6.4
LLY.TOEli Lilly CDR (CAD Hedged)Medium6.4
ABBVAbbVie Inclocked
MRKMerck & Company Inclocked
Unlock the full peer comparison →

Stryker Corporation stock at a glance

Stryker Corporation stock (SYK) is evaluated entirely rule-based in the StockScorer model. It currently reaches a StockScorer score of 4.5 out of 10, which corresponds to a low match with the underlying strategies. The classification is deliberately neutral and is not a recommendation to buy, hold or sell.

18 strategies evaluate this stock. Profitability metrics carry the most weight: margins, return on capital and earnings quality. Value, growth and dividend approaches feed in as well.

Sector classification: Healthcare

Stryker Corporation is assigned to the Healthcare sector. The sector classification makes it possible to compare the stock with peers from the same sector, for example in the peer comparison further up this page.

Frequently asked questions about Stryker Corporation stock

How does Stryker Corporation stock (SYK) score in the StockScorer model?
Stryker Corporation stock reaches a StockScorer score of 4.5 out of 10, which is a low match with the rule-based strategies. It fits the Profitability category best. All values are purely rule-based and updated every business day.
What is Stryker Corporation's P/E ratio?
Stryker Corporation stock currently has a P/E ratio of 32.1, a P/B ratio of 4.6, an equity ratio of 46.9 % and a return on equity (ROE) of 14.5 %.
What sector is Stryker Corporation in?
Stryker Corporation is assigned to the Healthcare sector. StockScorer uses the sector classification, among other things, to relate the stock to comparable peers from the same sector.

Unlock the full analysis for free

Signed up in 30 seconds. Free, cancel anytime.

  • ✓ More metrics: margin, debt, cash flow and more
  • ✓ Full peer comparison within the same sector
  • ✓ See the match across all strategies in detail
  • ✓ Apply your own scoring profile to any stock
  • ✓ Add the stock to your watchlist and track score changes
  • ✓ Daily updated ratings for 500+ stocks
Start for free →Already registered? Log in now

Not investment advice. The match shown reflects rule-based criteria and is not a recommendation to buy, hold or sell. Further metrics are available after a free sign-up.

Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.

How StockScorer rates every stock is explained on the methodology page.